Pharmacelera
PrivateLast Round
VC Round
Feb 18, 2026
Est. Valuation
$10.18M
Total Funding Raised
$5.24M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Pharmacelera operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a VC Round in February 2026.
Pharmacelera is a healthcare technology company that develops and provides computer-aided drug design (CADD) software and services applying quantum mechanics and artificial intelligence for drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pharmacelera Comparables
Compare Pharmacelera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioSolveIT | 86% | |
| Chemical Computing Group | 81% | |
| BEIT | 81% |
For institutional investors. Book with your work email.
Pharmacelera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 18, 2026 | ||||
| Grant | Dec 1, 2024 | ||||
| Grant | Apr 1, 2023 | ||||
| Crowdfunding | Jan 31, 2023 | ||||
| Crowdfunding | May 1, 2021 | ||||
Grant | May 19, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pharmacelera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noso Capital | VC Round |
| European Innovation Council Fund | Grant |
| Ministerio de Economía, Comercio y Empresa | Grant |
| Inveready | VC Round |
| European Commission | Grant |
| European Regional Development Fund | Grant |
| HERAN Partners | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 6, representing 21% of headcount.
- May 3, 2026
Grew 17% QoQ, from 24 to 28 employees.
For institutional investors. Book with your work email.
Pharmacelera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pharmacelera's valuation, stock price, and market status.
Is Pharmacelera a public or private company?
Pharmacelera is a private company.
What is the current stock price of Pharmacelera?
Pharmacelera is a private company, so its shares have no public market price. Caplight tracks Pharmacelera's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pharmacelera worth (valuation)?
Pharmacelera's valuation is estimated at $10.2M based on funding round data.
Can I buy Pharmacelera stock?
Pharmacelera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pharmacelera's last funding round?
Pharmacelera's most recent funding round was VC Round on February 18, 2026.
Who are the main investors in Pharmacelera?
Key investors in Pharmacelera include HERAN Partners, General Inception.
Will Pharmacelera IPO soon?
No public IPO plans have been announced for Pharmacelera.
How can I track Pharmacelera secondary market activity?
Caplight tracks bids, offers, and trades in Pharmacelera's shares on secondary markets.